CEL-1000 Peptide Effective Against Viral Encephalitis in Mice
More than 100 different types of viruses can cause acute encephalitis. In the United States, the most frequently reported causes are herpes simplex virus type 1 (HSV-1) and viruses spread by insects. Antiviral drugs are available for the treatment of herpes simplex virus infections, but antiviral drugs are not available for other encephalitis causing viruses.
Daniel Zimmerman, Senior Vice President of Research, Cellular Immunology of CEL-SCI commented, "We believe that there could be significant potential for CEL-1000 as a possible treatment for viral encephalitis. Earlier studies in Dr. Rosenthal's lab with Dr. Neena Goel had shown high levels of protection in animal studies against Herpes Simplex Virus. Other researchers have shown that CEL-1000 also protects against malaria and cancer in animal models. These studies suggest that CEL-1000 modulates the immune system to more effectively fight different diseases."
CEL-1000 is a modified version of a human immune-based protein known to bind to both human and mouse immune cells and appears to act by enhancing the host's protective immune response.
Most read news
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.